Maitri Porecha

Mumbai

Correspondent at DNA India

Featured in: Favicon

dnaindia.com Favicon

thehindubusinessline.com

Articles

Covid-19: Biocon to amend phase-4 trial protocol for psoriasis drug Itolizumab

Aug 3, 2020 | thehindubusinessline.com | Maitri Porecha
Drug controller instructs Serum Institute to revise protocol for Oxford Covid-19 vaccine clinical trial

Jul 29, 2020 | thehindubusinessline.com | Maitri Porecha
Health Ministry dragged to court for not releasing AIIMS Bhopal construction dues

Jul 29, 2020 | thehindubusinessline.com | Maitri Porecha
Centre announces ₹10,000-cr booster for local drug production

Jul 27, 2020 | thehindubusinessline.com | Maitri Porecha
Covid-19 related lockdown may potentially lead to two lakh additional TB cases in India: Study

Jul 25, 2020 | thehindubusinessline.com | Maitri Porecha
Covid-19 antibody kits: DCGI cancels import license for 3 firms, suspends 15 others

Jul 25, 2020 | thehindubusinessline.com | Maitri Porecha
Covid-19 drugs: What you must know with Maitri Porecha

Jul 18, 2020 | thehindubusinessline.com | Maitri Porecha
Despite early gains, Kerala stares yet again at Covid-19 crisis

Jul 16, 2020 | thehindubusinessline.com | Maitri Porecha
Clinical trials ‘wanting’ for Itolizumab and Tocilizumab

Jul 14, 2020 | thehindubusinessline.com | Maitri Porecha
Covid-19 antibody test: It’s advantage private labs

Jul 7, 2020 | thehindubusinessline.com | Maitri Porecha

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →